| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.65B | +21.2% |
| Cost of Revenue | $8.61B | +19.5% |
| Gross Profit | $1.03B | +37.1% |
| R&D Expense | $78.0M | +28.1% |
| SG&A Expense | $293.5M | -3.2% |
| Operating Income | $599.3M | +77.2% |
| Pre-tax Income | $532.2M | +73.9% |
| Income Tax | $104.2M | +69.2% |
| Net Income | $428.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $423.3M | +14.3% |
| Accounts Receivable | $2.07B | +15.2% |
| Inventory | $1.76B | -16.3% |
| Current Assets | $4.51B | +0.0% |
| Total Assets | $5.99B | +1.7% |
| Current Liabilities | $3.02B | -6.2% |
| Long-term Debt | $770.2M | +18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $473.9M | +45.3% |
| Investing Cash Flow | -$212.5M | -73.6% |
| Financing Cash Flow | -$208.5M | -0.3% |
| +75.1% |
| EPS (Basic) | $3.62 | +78.3% |
| EPS (Diluted) | $3.61 | +77.8% |
| Total Liabilities |
| $4.09B |
| -0.7% |
| Stockholders' Equity | $1.90B | +7.1% |